Audrey L Bender, Executrix

Title: Audrey L Bender: Innovator in Nontoxic Aspirin Composition

Introduction

Audrey L Bender is a notable inventor and Executrix based in Huntington Valley, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly with her innovative approach to aspirin formulations. Her work focuses on creating safer and more effective analgesic compositions.

Latest Patents

Audrey L Bender holds a patent for a sublingually absorbable nontoxic aspirin composition. This patent describes an analgesic aspirin formulation that includes acetylsalicylic acid and unreacted glycine in a specific ratio. The composition is designed to render the aspirin nontoxic upon ingestion while also allowing for sublingual absorption, enhancing its efficacy and safety.

Career Highlights

Throughout her career, Audrey has been associated with Dynatech Laboratories, Inc., where she has contributed her expertise in pharmaceutical innovations. Her work has been instrumental in advancing the development of safer medication options for consumers.

Collaborations

Audrey has collaborated with various professionals in her field, including her late coworker, Charles E Bender. Their partnership has likely fostered a creative environment that encourages innovation and the pursuit of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Audrey L Bender's contributions to the field of pharmaceuticals, particularly her patent for a nontoxic aspirin composition, highlight her role as an innovator. Her work continues to influence the development of safer medication options, showcasing the importance of innovation in healthcare.